glp-1 receptors in the body Physiology of secretion and action on GLP-1 Peptidyl and Non-Peptidyl Oral Glucagon-Like

GIP Action: GIP is another incretin hormone that plays a role in glucose-dependent insulin secretion and may also influence fat metabolism and energy expenditure

Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.02 0.05 mg (= 25 clicks) Duration: 4 6 weeks Frequency: Daily Cycle Interval: 4 weeks off before repeating Goal / Description: Baseline anabolic signaling and muscle growth models

Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion and heartburn/acid reflux

5-8 In this regard, it is well recognised that the secretion and action of GIP and GLP-1 is disturbed in obesity and T2D, 5-10,16-18 which could also directly impact skeletal health